Covered recipient · General Payments record
NI SUN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2024
$1,168.30
- Reported across 38 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $898.91 | 30 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $274.53 | 4 |
| ABBVIE INC. | $202.93 | 7 |
| Novo Nordisk AS | $148.62 | 7 |
| PFIZER INC. | $97.19 | 4 |
| Ardelyx, Inc. | $71.41 | 3 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $40.42 | 2 |
| Phathom Pharmaceuticals, Inc. | $26.98 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $20.14 | 1 |
| Lilly USA, LLC | $16.69 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (30)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $12.11 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108273770 | CMS |
| ABBVIE INC. | $146.73 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108273772 | CMS |
| ABBVIE INC. | $14.00 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108273774 | CMS |
| ABBVIE INC. | $5.84 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108273776 | CMS |
| ABBVIE INC. | $7.33 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108273778 | CMS |
| ABBVIE INC. | $9.60 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108273780 | CMS |
| ABBVIE INC. | $7.32 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108273782 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $20.14 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147020579 | CMS |
| Amgen Inc. | $15.46 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117394056 | CMS |
| Amgen Inc. | $125.00 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117394060 | CMS |
| Amgen Inc. | $124.62 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117394062 | CMS |
| Amgen Inc. | $9.45 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117394058 | CMS |
| Ardelyx, Inc. | $24.33 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146747249 | CMS |
| Ardelyx, Inc. | $23.22 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146747251 | CMS |
| Ardelyx, Inc. | $23.86 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146747253 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.06 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118028066 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $21.36 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118028068 | CMS |
| Lilly USA, LLC | $16.69 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135917201 | CMS |
| Novo Nordisk Inc | $19.29 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100267130 | CMS |
| Novo Nordisk Inc | $18.50 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100458550 | CMS |
| Novo Nordisk Inc | $24.17 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100410579 | CMS |
| Novo Nordisk Inc | $22.71 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100652113 | CMS |
| Novo Nordisk Inc | $21.08 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100341602 | CMS |
| Novo Nordisk Inc | $19.50 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100260693 | CMS |
| Novo Nordisk Inc | $23.37 | 12/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100487619 | CMS |
| PFIZER INC. | $23.12 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131156786 | CMS |
| PFIZER INC. | $23.80 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131288660 | CMS |
| PFIZER INC. | $22.43 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131471326 | CMS |
| PFIZER INC. | $27.84 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131857825 | CMS |
| Phathom Pharmaceuticals, Inc. | $26.98 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151209143 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.